Director records verified
Padmaja Kalyani Sadhanala
Named in 17 filings across 1 BSE-listed company since 2025-11 — most recently at Venmax Drugs and Pharmaceuticals Ltd (2026-09).
Records through 2026-09-08 · refreshed as new filings arrive
Seen in filings at (from BSE disclosures)
Documented roles (from public records)
Pharmaids PharmaPromoter & Director · Until at least March 2022
Blue Nile Capital Advisory LimitedDirector · Active (per DIN 03096445 records)
Venmax Drugs and Pharmaceuticals LtdAdditional Director (Non-Executive, Non-Independent) · March 30, 2026 onwards
Common questions (from the filings record)
Who is Padmaja Kalyani Sadhanala in BSE filings?
Padmaja Kalyani Sadhanala is named in 17 filings across 1 BSE-listed company since 2025-11 — most recently at Venmax Drugs and Pharmaceuticals Ltd (2026-09). Records through 2026-09-08, from public exchange disclosures.
Which companies is Padmaja Kalyani Sadhanala named in?
Venmax Drugs and Pharmaceuticals Ltd (Board change filings ×5) — 17 filings, 2025-11 to 2026-09.
What documented roles does Padmaja Kalyani Sadhanala hold?
From public records: Pharmaids Pharma — Promoter & Director, Until at least March 2022; Blue Nile Capital Advisory Limited — Director, Active (per DIN 03096445 records); Venmax Drugs and Pharmaceuticals Ltd — Additional Director (Non-Executive, Non-Independent), March 30, 2026 onwards.
The Bench shows this person's documented history, their connections across listed companies, and what happened after their filings.